1. Home
  2. ROIV vs DRS Comparison

ROIV vs DRS Comparison

Compare ROIV & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.59

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

HOLD

Current Price

$34.13

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
DRS
Founded
2014
1969
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
8.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
DRS
Price
$21.59
$34.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$24.31
$46.83
AVG Volume (30 Days)
8.4M
827.0K
Earning Date
02-09-2026
10-29-2025
Dividend Yield
N/A
1.05%
EPS Growth
N/A
33.93
EPS
N/A
0.99
Revenue
$20,329,000.00
$3,569,000,000.00
Revenue This Year
N/A
$11.94
Revenue Next Year
$741.42
$6.66
P/E Ratio
N/A
$34.50
Revenue Growth
N/A
12.27
52 Week Low
$8.73
$28.17
52 Week High
$23.47
$49.31

Technical Indicators

Market Signals
Indicator
ROIV
DRS
Relative Strength Index (RSI) 51.86 47.07
Support Level $21.60 $33.96
Resistance Level $22.72 $34.89
Average True Range (ATR) 0.81 0.74
MACD -0.11 0.20
Stochastic Oscillator 43.03 65.04

Price Performance

Historical Comparison
ROIV
DRS

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: